The group of Dr. Susanne Dam Poulsen is responsible of WP9 and will test new prognostic biomarkers and potential treatments. Under the lead of Dr. Dam Poulsen biomarkers identified in WP4-8 will be integrated in algorithms to identify patients in need of a given treatment. Further work will involve preparing genetic and adaptive trial protocols that are conditionally pre-approved by ethics and regulatory authorities